Allogene Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 11/13/2024 | 30.03 M | $84.08 M | -3.94% | 14.35% |
TPG GP A, LLC | 11/14/2024 | 18.72 M | $52.41 B | 0.00% | 8.95% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 17.77 M | $49.76 M | 100.00% | 8.50% |
VANGUARD GROUP INC | 11/13/2024 | 8.33 M | $23.32 M | 1.61% | 3.98% |
STATE STREET CORP | 11/14/2024 | 7.01 M | $19.64 M | -8.54% | 3.35% |
CAPITAL WORLD INVESTORS | 11/13/2024 | 6.90 M | $19.31 M | 0.00% | 3.30% |
LYNX1 CAPITAL MANAGEMENT LP | 11/14/2024 | 6.20 M | $17.37 B | 178.35% | 2.97% |
PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 5.67 M | $15.87 M | -0.03% | 2.71% |
CITADEL ADVISORS LLC | 11/14/2024 | 5.04 M | $14.11 M | 105.99% | 2.41% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 4.84 M | $13.55 M | -16.44% | 2.31% |
WOODLINE PARTNERS LP | 11/14/2024 | 4.36 M | $12.22 M | 0.12% | 2.09% |
JPMORGAN CHASE & CO | 12/26/2024 | 4.09 M | $11.45 M | -0.91% | 1.95% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 3.23 M | $9.04 M | 14.43% | 1.54% |
WILDCAT CAPITAL MANAGEMENT, LLC | 11/08/2024 | 2.92 M | $8.18 B | 0.00% | 1.40% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/15/2024 | 2.87 M | $8.03 M | 0.00% | 1.37% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 2.80 M | $7.83 M | -5.50% | 1.34% |
DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 2.73 M | $7.65 M | 7.05% | 1.31% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 2.73 M | $7.63 M | 0.00% | 1.30% |
TWO SIGMA ADVISERS, LP | 11/14/2024 | 2.41 M | $6.75 M | 7.49% | 1.15% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 2.16 M | $6.06 M | 41.34% | 1.03% |
VIDA VENTURES ADVISORS, LLC | 10/08/2024 | 1.80 M | $5.03 M | 0.00% | 0.86% |
MORGAN STANLEY | 11/14/2024 | 1.72 M | $4.82 M | -20.19% | 0.82% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 1.63 M | $4.58 M | 461.58% | 0.78% |
VESTAL POINT CAPITAL, LP | 11/14/2024 | 1.50 M | $4.20 M | -31.82% | 0.72% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.18 M | $3.30 M | 0.04% | 0.56% |
DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 1.05 M | $2.94 M | 73.54% | 0.50% |
TD ASSET MANAGEMENT INC | 11/01/2024 | 677,140 | $1.97 M | -15.29% | 0.32% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 642,009 | $1.80 M | -63.27% | 0.31% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 583,925 | $1.63 M | 34.95% | 0.28% |
ZACKS INVESTMENT MANAGEMENT | 11/14/2024 | 516,601 | $1.45 M | 100.00% | 0.25% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 486,023 | $1.36 M | 1.17% | 0.23% |
SUPERSTRING CAPITAL MANAGEMENT LP | 11/14/2024 | 478,115 | $1.34 M | -30.70% | 0.23% |
NORDEA INVESTMENT MANAGEMENT AB | 11/05/2024 | 451,006 | $1.30 M | -28.94% | 0.22% |
JANE STREET GROUP, LLC | 11/15/2024 | 437,721 | $1.23 M | -27.67% | 0.21% |
CERITY PARTNERS LLC | 11/12/2024 | 432,382 | $1.21 M | 0.05% | 0.21% |
COASTAL BRIDGE ADVISORS, LLC | 11/14/2024 | 405,847 | $1.14 M | -0.25% | 0.19% |
UBS GROUP AG | 11/14/2024 | 347,340 | $972,552 | 15.66% | 0.17% |
BARCLAYS PLC | 11/19/2024 | 342,973 | $959,000 | 101.48% | 0.16% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 317,619 | $889,334 | -12.35% | 0.15% |
RAFFERTY ASSET MANAGEMENT, LLC | 11/13/2024 | 316,946 | $887,449 | -45.81% | 0.15% |
SWISS NATIONAL BANK | 11/07/2024 | 264,900 | $741,720 | -7.70% | 0.13% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 258,002 | $722,406 | 43.63% | 0.12% |
PARTNERS CAPITAL INVESTMENT GROUP, LLP | 11/05/2024 | 254,845 | $713,566 | -43.97% | 0.12% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 254,239 | $711,869 | 6.35% | 0.12% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 247,564 | $694,552 | -6.34% | 0.12% |
CAXTON ASSOCIATES LP | 11/14/2024 | 242,102 | $677,886 | -48.06% | 0.12% |
MITSUBISHI UFJ KOKUSAI ASSET MANAGEMENT CO., LTD. | 11/08/2024 | 236,696 | $662,749 | -3.76% | 0.11% |
ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 210,078 | $588,218 | 0.00% | 0.10% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 199,421 | $558,379 | 21.94% | 0.10% |
SQUAREPOINT OPS LLC | 11/14/2024 | 188,497 | $527,792 | 48.86% | 0.09% |
Allogene Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 199 institutional investors and hedge funds held shares of Allogene Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 30.03 M
TPG GP A, LLC: 18.72 M
BlackRock Funding, Inc. /DE: 17.77 M
VANGUARD GROUP INC: 8.33 M
STATE STREET CORP: 7.01 M
Capital World Investors: 6.9 M
78.58% of Allogene Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 200.88 M shares in the last 24 months. This purchase volume represents approximately $443.94 M in transactions.